FusionPharm, Inc. Appoints Shane Bohlender as CFO

DENVER, July 25, 2011 /PRNewswire/ -- FusionPharm, Inc. (PINKSHEETS: FSPM), is proud to announce the addition of Shane Bohlender as CFO. Mr. Bohlender, a seasoned CPA with 18 years of experience, worked for Deloitte in San Francisco and New York, PWC in London, headed the finance department of a subsidiary of France Telecom, and recently graduated from Thunderbird's esteemed Executive MBA program.

"As the company moves towards achieving a fully reporting status by years end I will provide clear reporting of the company's financial position and its future potential and will help Mr. Dittman realize that potential. I see a great future for FusionPharm and immediate value in its services to this new and growing industry. We have the right people in the right place at the right time, and are positioned to become the top nationwide service provider.  

ABOUT FUSIONPHARM, INC.

FusionPharm, Inc. (www.fusionpharminc.com) provides a focused variety of support products and ancillary services primarily to the medical cannabis industry. More specifically, FusionPharm provides specialty equipment, financing, consulting and other industry-specific services to Medical Cannabis Centers, Infused Product Manufacturers and cultivation professionals primarily in the State of Colorado.

The Company is NOT engaged in growing, harvesting, cultivation, possession or distribution of marijuana.

NOTES ABOUT FORWARD-LOOKING STATEMENTS :

Except for any historical information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, including those described in the Company's Securities and Exchange Commission reports and filings. Certain statements contained in this release that are not historical facts constitute forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, and are intended to be covered by the safe harbors created by that Act. Reliance should not be placed on forward-looking statements because they involve unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied. Forward-looking statements may be identified by words such as estimates, anticipates, projects, plans, expects, intends, believes, should and similar expressions and by the context in which they are used. Such statements are based upon current expectations of the Company and speak only as of the date made. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which they are made.

SOURCE FusionPharm, Inc.

Copyright 2011 PR Newswire